Valsartan (Angiotan or Diovan) is an angiotensin II receptor antagonist (more commonly called an ARB, or angiotensin receptor blocker), with particularly high affinity for the type I (AT1) angiotensin receptor. In December 1996, Valsartan was approved by FDA. Complete report is available @ http://www.chinamarketresearchreports.com/114712.html

1. Investigation Report on China Valsartan
Market, 2009-2018
by
Research In China
Explore all reports for “Life Sciences”
market
@
http://www.chinamarketresearchreports.com/cat/li
fe-sciences.html .
© ChinaMarketResearchReports.com ;
sales@chinamarketresearchreports.com ;
+1 888 391 5441

2. Investigation Report on China Valsartan
Market, 2009-2018
The collection of „Life Sciences‟ market research reports has a new
addition of “Investigation Report on China Valsartan Market, 20092018”On chinamarketresearchreports.com. Valsartan (Angiotan or
Diovan) is an angiotensin II receptor antagonist (more commonly called
an ARB, or angiotensin receptor blocker), with particularly high affinity
for the type I (AT1) angiotensin receptor. In December 1996, Valsartan
was approved by FDA. In the US, UK and Australia, valsartan is
marketed by Novartis under the trade name Diovan. In 1998, Valsartan
was registered by Novartis in China with "Daiwen" as its brand name.
After Valsartan, Novartis developed Valsartan compound preparation. In
October 1997, valsartan/hydrochlorothiazide was approved by FDA with
"CoDiovan" as its brand name; New developed amlodipine/valsartan
(Exforge) was also approved to the market.
There are many enterprises producing APIs and finished products of
Valsartan. The market share of finished products is mainly occupied by
Novartis, which is above 85% by sales value every year.
Inquire for discount @
http://www.chinamarketresearchreports.com/contacts/inquiry.php?nam
e=114712
© ChinaMarketResearchReports.com ;
sales@chinamarketresearchreports.com ;
+1 888 391 5441

3. Investigation Report on China Valsartan
Market, 2009-2018
In China, the number of hypertensive patients has exceeded 200 million
so the market prospect of Valsartan is bright.
Through this report, the readers can acquire the following
information:
Market Share of Major Valsartan Manufacturers in Sampling Hospitals in
China
Sales price of valsartan in hospital market in China
Major valsartan enterprises in China
Market share of valsartan by dosage form in hospital market in China
Prospect of China valsartan market
The Following Enterprises and People Are Recommended to Purchase
This Report:
Valsartan API and finished product manufacturers
Medical Institutions
Investors /research agencies focusing on valsartan market
Complete report is available @
http://www.chinamarketresearchreports.com/114712.html
© ChinaMarketResearchReports.com ;
sales@chinamarketresearchreports.com ;
+1 888 391 5441

4. Investigation Report on China Valsartan
Market, 2009-2018
Table of Contents
1 Relevant Concepts of Valsartan
1.1 Indication
1.2 Sales Status on the Global Market
2 Market Overview of Valsartan in China
2.1 Patent Status
2.2 Major Manufacturers
2.3 Market Size
3 Investigation on Sales Value of Valsartan in China, 2009-2013
3.1 Total Sales Value
3.2 Sales Value by Region
4 Investigation on Market Share of Major Valsartan
Manufacturers in China, 2009-2013
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
Inquire for discount @
http://www.chinamarketresearchreports.com/contacts/inquiry.php?nam
e=114712
© ChinaMarketResearchReports.com ;
sales@chinamarketresearchreports.com ;
+1 888 391 5441

5. Investigation Report on China Valsartan
Market, 2009-2018
5 Investigation on Market Size of Valsartan by Dosage Form in
China, 2009-2013
5.1 Market Share by Sales Value and Dosage Form
5.2 Market Share by Sales Volume and Dosage Form
6 Reference Price of Valsartan in Hospital Market in China, 2013
6.1 Tianda Group
6.2 Livzon Pharmaceutical Factory of Livzon Group
6.3 Beijing Novartis Pharma Co., Ltd.
6.4 Beijing Saike Pharmaceutical Co., Ltd.
6.5 Guilin Winsun Pharmaceutical Co., Ltd.
6.6 Changzhou Siyao Pharmaceutical Co., Ltd.
6.7 Hainan Bright Future Pharmaceutical Co.,Ltd.
6.8 Hainan Hualon Pharmaceutical Co., Ltd.
7 Anallysis on Major Valsartan Manufacturers in China, 20092013
Complete report is available @
http://www.chinamarketresearchreports.com/114712.html
© ChinaMarketResearchReports.com ;
sales@chinamarketresearchreports.com ;
+1 888 391 5441

6. Investigation Report on China Valsartan
Market, 2009-2018
7.1 Beijing Novartis
7.2 Beijing Saike
7.3 Changzhou Siyao
7.4 Hainan Hualon
7.5 Lunan Better
8 Prospect of China Valsartan Market, 2014-2018
8.1 Forecast on Market Size
8.2 Forecast on Competition Pattern
List of Charts
Chart Valsartan Products Approved to Market in China, 2014
Chart Forecast on Market Size of Hospital-use Valsartan in China, 20142018
Chart Sales Value of Valsartan in Global Market, 2009-2013
Chart Sales Value of Valsartan in Hospital Market in China, 2009-2013
Chart Sales Value of Valsartan by Region in China, 2009-2013
Chart Market Share of Valsartan Enterprises by Sales Value in
China, 2009-2013
Inquire for discount @
http://www.chinamarketresearchreports.com/contacts/inquiry.php?nam
e=114712
© ChinaMarketResearchReports.com ;
sales@chinamarketresearchreports.com ;
+1 888 391 5441